Faster medication increase for heart failure with weak pumping
Part of Heart & circulation clinical trials.
This trial tests a new, faster way to increase heart failure medications during a hospital stay, aiming to get patients on the right doses sooner. It is for people with weak heart pumping (ejection fraction 40% or less) who are currently in the hospital for heart failure and are on low doses of standard medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are currently in the hospital for heart failure with congestion (fluid buildup)
- Your heart's pumping strength (ejection fraction) is 40% or less
- You are only taking small doses of certain heart failure medications (like ACE inhibitors, ARBs, beta-blockers, or MRAs)
- Your blood pressure is above 90 mmHg, heart rate is at least 60 bpm, and potassium levels are normal
- You do not have severe kidney disease, recent heart attack/stroke, or other serious health issues that could affect participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This study looks at the best strategies to gradually increase ("up-titrate") common heart failure medicines while you’re still in the hospital. It may help doctors find safer, more effective ways to reach target doses after acute heart failure.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
This study helps doctors adjust heart failure medications based on your individual response and biomarkers (blood markers). If your heart isn't pumping well enough and you're not yet on the full recommended dose of heart failure medications, this trial may help optimize your treatment plan.
This study tests whether a new drug called AC01 can help people with advanced heart failure (where the heart doesn't pump well) feel better and stay healthier. You'll be randomly assigned to receive either AC01 or placebo, and researchers will monitor your heart health closely throughout the study.
This trial tests a program to manage heart failure at home after you leave the hospital. It aims to safely adjust your medications to optimal doses while you recover at home.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.